ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Wen-Jing Liu
Matched on OpenAlex author ID A5140095791. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 6
- Safety and oncologic efficacy of robotic surgery compared to open surgery after neoadjuvant therapy for pancreatic cancer. Co-author DOI 10.1186/s12893-026-03942-9↗
- Integrative metagenomic and metabolomic profiling identifies gut microbial and metabolite signatures associated with lymph node metastasis in pancreatic cancer. Co-author DOI 10.3389/fmicb.2025.1706084↗
- MLH1 Inhibits Metastatic Potential of Pancreatic Ductal Adenocarcinoma via Downregulation of GPRC5C. Co-author DOI 10.1016/j.labinv.2024.102107↗
- High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.prp.2017.11.013↗
- Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.4103/0366-6999.247211↗
- MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreatic cancer. Co-author DOI 10.1007/s11605-013-2230-5↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Li Zhou · 4 shared papers, 2013–2024 · strength 0.50
- Paper MLH1 Inhibits Metastatic Potential of Pancreatic Ductal Adenocarcinoma via Downregulation of GPRC5C. DOI 10.1016/j.labinv.2024.102107↗
- Paper High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.prp.2017.11.013↗
- Paper Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.4103/0366-6999.247211↗
- Pengyu Li · 2 shared papers, 2025–2026 · strength 0.50
- Paper Safety and oncologic efficacy of robotic surgery compared to open surgery after neoadjuvant therapy for pancreatic canc… DOI 10.1186/s12893-026-03942-9↗
- Paper Integrative metagenomic and metabolomic profiling identifies gut microbial and metabolite signatures associated with ly… DOI 10.3389/fmicb.2025.1706084↗
- Zhiyong Liang · 3 shared papers, 2018–2026 · strength 0.43
- Paper Safety and oncologic efficacy of robotic surgery compared to open surgery after neoadjuvant therapy for pancreatic canc… DOI 10.1186/s12893-026-03942-9↗
- Paper High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.prp.2017.11.013↗
- Paper Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.4103/0366-6999.247211↗
- Jianzhou Liu · 1 shared paper, 2024 · strength 0.28
- Jun Lü · 1 shared paper, 2024 · strength 0.28
- Min Dai · 1 shared paper, 2026 · strength 0.25
- Haitao Zhang · 1 shared paper, 2026 · strength 0.25
- Huadan Xue · 1 shared paper, 2026 · strength 0.25
- Hanyu Zhang · 1 shared paper, 2025 · strength 0.25
- Menghua Dai · 1 shared paper, 2025 · strength 0.25
- Yu-Pei Zhao · 3 shared papers, 2013–2018 · strength 0.22
- Paper High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.prp.2017.11.013↗
- Paper Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.4103/0366-6999.247211↗
- Paper MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreatic cancer. DOI 10.1007/s11605-013-2230-5↗
- Taiping Zhang · 3 shared papers, 2013–2018 · strength 0.22
- Paper High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.prp.2017.11.013↗
- Paper Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.4103/0366-6999.247211↗
- Paper MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreatic cancer. DOI 10.1007/s11605-013-2230-5↗
- Lei You · 3 shared papers, 2013–2018 · strength 0.22
- Paper High expression of GRK3 is associated with favorable prognosis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.prp.2017.11.013↗
- Paper Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.4103/0366-6999.247211↗
- Paper MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreatic cancer. DOI 10.1007/s11605-013-2230-5↗
- Hong Shu · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.